Skip to content

The effects of a 2-week whole-body electromyostimulation in cancer patients

Short-term whole-body electromyostimulation in cancer patients: a single-arm trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN68069634
Enrollment
15
Registered
2024-11-07
Start date
2019-06-01
Completion date
Unknown
Last updated
2025-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patients, with diverse entities, disease stages, under acute therapy and after medical treatment Cancer

Interventions

The patients performed four WB-EMS exercise sessions in 2 weeks. The training duration was 15 minutes in the first week, increasing to 17 minutes in the second week. The training was performed with an

Sponsors

University Hospital Cologne
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed with a solid tumor 2. Receive concurrent medical therapy, including chemotherapy, radiation, immunotherapy or were cancer survivors, including receiving endocrine therapy 3. Over 18 years of age 4. Gave informed consent 5. Received medical clearance to exercise by a physician

Exclusion criteria

Exclusion criteria: 1. Acute severe cardiovascular or neurological diseases 2. Patients with electrical implants (s.a. pacemaker or defibrillation) 3. Osteosynthesis-related metal in the body or ongoing pregnancy 4. Patients with acute venous thrombosis 5. Major surgeries in stimulation areas (e.g. heart surgery, abdominal or pelvic surgeries, orthopedic surgeries, neurosurgical procedures) within the last 3 months

Design outcomes

Primary

MeasureTime frame
Feasibility is measured using drop-out rate, training adherence and adverse events at the end of the intervention

Secondary

MeasureTime frame
1. Body composition measured using Bioelectrical Impedance Analysis (BIA) at baseline and post-test 2. Physical performance measured using modified step test according to the World Health Organization (WHO) scheme, the hypothetical one-repetition maximum and the handgrip method at baseline and post-test 3. Quality of life measured using the Quality-of-Life Questionnaire (EORTC-QLQ-C30) developed by the European Organisation for Research and Treatment of Cancer at baseline and post-test 4. Anxiety and depressive symptoms measured using the Anxiety and Depression Scale at baseline and post-test 5. Fatigue syndrome measured using the Multidimensional Fatigue Inventory at baseline and post-test 6. Perceived physical condition measured using the German WKV-Questionnaire before and after every WB-EMS exercise session

Countries

Germany

Contacts

Public ContactJane;Timo Kersten;Niels

;

jane.kersten@uk-koeln.de;timo.niels@uk-koeln.de+49 (0)22147842646;+49 (0)22147842646

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026